TOMZ

TOMZ
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.012M ▲ | $1.485M ▼ | $-450.348K ▲ | -22.388% ▲ | $-0.02 ▲ | $-251.421K ▲ |
| Q2-2025 | $1.031M ▼ | $1.81M ▲ | $-1.238M ▼ | -120.017% ▼ | $-0.062 ▼ | $-1.023M ▼ |
| Q1-2025 | $1.577M ▲ | $1.706M ▼ | $-255.593K ▲ | -16.212% ▲ | $-0.013 ▲ | $-28.792K ▲ |
| Q4-2024 | $1.069M ▼ | $2.62M ▲ | $-3.256M ▼ | -304.527% ▼ | $-0.16 ▼ | $-3.035M ▼ |
| Q3-2024 | $2.542M | $1.412M | $58.962K | 2.319% | $0.003 | $261.82K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $490.022K ▼ | $8.045M ▼ | $5.839M ▲ | $2.206M ▼ |
| Q2-2025 | $569.45K ▼ | $8.476M ▼ | $5.819M ▼ | $2.657M ▼ |
| Q1-2025 | $674.181K ▲ | $9.958M ▲ | $6.114M ▲ | $3.843M ▼ |
| Q4-2024 | $664.879K ▼ | $9.694M ▼ | $5.595M ▲ | $4.099M ▼ |
| Q3-2024 | $809.037K | $12.462M | $5.107M | $7.355M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-450.348K ▲ | $-113.478K ▲ | $-65.95K ▲ | $100K ▼ | $-79.428K ▲ | $-113.48K ▲ |
| Q2-2025 | $-1.238M ▼ | $-187.604K ▲ | $-67.127K ▼ | $150K ▼ | $-104.731K ▼ | $-190.269K ▲ |
| Q1-2025 | $-255.593K ▲ | $-275.698K ▼ | $0 ▲ | $285K ▲ | $9.302K ▲ | $-275.698K ▼ |
| Q4-2024 | $-3.256M ▼ | $12.709K ▼ | $-156.867K ▼ | $0 | $-144.158K ▼ | $-144.158K ▼ |
| Q3-2024 | $58.962K | $105.311K | $-5.384K | $0 | $99.927K | $99.927K |
Revenue by Products
| Product | Q3-2023 | Q4-2023 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Product and Service Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
International | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Service And Training | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
SteraMist PRoduct | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
TOMI Environmental Solutions combines a distinctive, well-regarded disinfection technology with a very small, still-unprofitable financial profile. The business has yet to scale revenue or earnings in a consistent way, and its modest balance sheet and weak cash generation underline execution and funding risks if growth stalls. On the strategic side, its proprietary ionized hydrogen peroxide platform, regulatory approvals, and emphasis on integrated systems and life-sciences partnerships create a targeted competitive edge in specific, high-requirement settings. The core question for the future is whether TOMI can convert its strong technical story and integration pipeline into sustained commercial traction, recurring revenue, and ultimately a more robust and self-sustaining financial base, while competing against much larger industry incumbents.
NEWS
November 26, 2025 · 8:30 AM UTC
TOMI Environmental Solutions Announces $3 Million Custom Integration Pipeline with Strategic Life Sciences Partnerships
Read more
November 17, 2025 · 8:30 AM UTC
TOMI Environmental Solutions, Inc. Announces Filing of $50 Million Universal Shelf Registration Statement and Equity Line of Credit
Read more
November 10, 2025 · 4:30 PM UTC
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2025 Financial Results on November 14, 2025
Read more
October 6, 2025 · 8:30 AM UTC
TOMI Environmental Solutions to Present at the LD Micro Main Event XIX
Read more
October 1, 2025 · 4:30 PM UTC
TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors
Read more
About TOMI Environmental Solutions, Inc.
https://tomimist.comTOMI Environmental Solutions, Inc., a bacteria decontamination and infectious disease control company, provides environmental solutions for indoor surface decontamination in the United States and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.012M ▲ | $1.485M ▼ | $-450.348K ▲ | -22.388% ▲ | $-0.02 ▲ | $-251.421K ▲ |
| Q2-2025 | $1.031M ▼ | $1.81M ▲ | $-1.238M ▼ | -120.017% ▼ | $-0.062 ▼ | $-1.023M ▼ |
| Q1-2025 | $1.577M ▲ | $1.706M ▼ | $-255.593K ▲ | -16.212% ▲ | $-0.013 ▲ | $-28.792K ▲ |
| Q4-2024 | $1.069M ▼ | $2.62M ▲ | $-3.256M ▼ | -304.527% ▼ | $-0.16 ▼ | $-3.035M ▼ |
| Q3-2024 | $2.542M | $1.412M | $58.962K | 2.319% | $0.003 | $261.82K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $490.022K ▼ | $8.045M ▼ | $5.839M ▲ | $2.206M ▼ |
| Q2-2025 | $569.45K ▼ | $8.476M ▼ | $5.819M ▼ | $2.657M ▼ |
| Q1-2025 | $674.181K ▲ | $9.958M ▲ | $6.114M ▲ | $3.843M ▼ |
| Q4-2024 | $664.879K ▼ | $9.694M ▼ | $5.595M ▲ | $4.099M ▼ |
| Q3-2024 | $809.037K | $12.462M | $5.107M | $7.355M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-450.348K ▲ | $-113.478K ▲ | $-65.95K ▲ | $100K ▼ | $-79.428K ▲ | $-113.48K ▲ |
| Q2-2025 | $-1.238M ▼ | $-187.604K ▲ | $-67.127K ▼ | $150K ▼ | $-104.731K ▼ | $-190.269K ▲ |
| Q1-2025 | $-255.593K ▲ | $-275.698K ▼ | $0 ▲ | $285K ▲ | $9.302K ▲ | $-275.698K ▼ |
| Q4-2024 | $-3.256M ▼ | $12.709K ▼ | $-156.867K ▼ | $0 | $-144.158K ▼ | $-144.158K ▼ |
| Q3-2024 | $58.962K | $105.311K | $-5.384K | $0 | $99.927K | $99.927K |
Revenue by Products
| Product | Q3-2023 | Q4-2023 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Product and Service Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
International | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Service And Training | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
SteraMist PRoduct | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
TOMI Environmental Solutions combines a distinctive, well-regarded disinfection technology with a very small, still-unprofitable financial profile. The business has yet to scale revenue or earnings in a consistent way, and its modest balance sheet and weak cash generation underline execution and funding risks if growth stalls. On the strategic side, its proprietary ionized hydrogen peroxide platform, regulatory approvals, and emphasis on integrated systems and life-sciences partnerships create a targeted competitive edge in specific, high-requirement settings. The core question for the future is whether TOMI can convert its strong technical story and integration pipeline into sustained commercial traction, recurring revenue, and ultimately a more robust and self-sustaining financial base, while competing against much larger industry incumbents.
NEWS
November 26, 2025 · 8:30 AM UTC
TOMI Environmental Solutions Announces $3 Million Custom Integration Pipeline with Strategic Life Sciences Partnerships
Read more
November 17, 2025 · 8:30 AM UTC
TOMI Environmental Solutions, Inc. Announces Filing of $50 Million Universal Shelf Registration Statement and Equity Line of Credit
Read more
November 10, 2025 · 4:30 PM UTC
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2025 Financial Results on November 14, 2025
Read more
October 6, 2025 · 8:30 AM UTC
TOMI Environmental Solutions to Present at the LD Micro Main Event XIX
Read more
October 1, 2025 · 4:30 PM UTC
TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors
Read more

CEO
Halden Stuart Shane
Compensation Summary
(Year 2024)

CEO
Halden Stuart Shane
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-09-15 | Reverse | 1:8 |
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades
Grade Summary
Institutional Ownership

VANGUARD GROUP INC
602.43K Shares
$475.92K

GEODE CAPITAL MANAGEMENT, LLC
134.927K Shares
$106.592K

SUSQUEHANNA INTERNATIONAL GROUP, LLP
101.28K Shares
$80.011K

STATE STREET CORP
52.209K Shares
$41.245K

BDO WEALTH ADVISORS, LLC
48.751K Shares
$38.513K

CHOREO, LLC
43.842K Shares
$34.635K

RENAISSANCE TECHNOLOGIES LLC
33.8K Shares
$26.702K

CITADEL ADVISORS LLC
17.551K Shares
$13.865K

AMERICAN PORTFOLIOS ADVISORS
17.5K Shares
$13.825K

NORTHERN TRUST CORP
15.835K Shares
$12.51K

SPINNAKER INVESTMENT GROUP, LLC
14.738K Shares
$11.643K

COMMONWEALTH EQUITY SERVICES, LLC
11.059K Shares
$8.737K

ADVISOR GROUP HOLDINGS, INC.
9.8K Shares
$7.742K

TOWER RESEARCH CAPITAL LLC (TRC)
4.351K Shares
$3.437K

UBS GROUP AG
2.5K Shares
$1.975K

BANK OF AMERICA CORP /DE/
491 Shares
$387.89

ALLWORTH FINANCIAL LP
344 Shares
$271.76

CITIGROUP INC
16 Shares
$12.64

BARCLAYS PLC
9 Shares
$7.11

SBI SECURITIES CO., LTD.
1 Shares
$0.79
Summary
Only Showing The Top 20


